Fortis Healthcare ne H1 2026 ke results mein mast growth dikhayi hai. Revenue badh kar **₹5,279.86 Crore** ho gaya hai, jabki pichle saal ye **₹4,498.16 Crore** tha. Profit **₹578.77 Crore** par stable bana hua hai.
Performance ka report card
Company ne H1 ke liye jo numbers dikhaye hain, usse saaf hai ki hospital aur diagnostic ka business zoron par hai. Revenue mein acchi-kasi badhotri dikhi hai, jo ₹5,279.86 Crore tak pahunch gayi hai. Halanki, net profit ₹578.77 Crore par flat hai, matlab company ka focus abhi expansion par zyada hai.
Investors ke liye kya hai?
Retail investors ke liye achi baat ye hai ki audit report 'unmodified' hai, iska matlab accounts mein koi jhol nahi hai. Revenue ka badhna ye dikhata hai ki core operations tagde chal rahe hain.
Purane kisse aur regulatory pange
Company abhi bhi purane promoters se jude SFIO aur EOW ke investigation ko handle kar rahi hai. Ye sab legal formalities ka part hai aur management ne bola hai ki wo authorities ko poora support kar rahe hain. Sath hi, 'Fortis' aur 'Agilus' brand ko lekar trademark case bhi chal raha hai.
Aage kya?
Board ne internal controls ko aur tight kar diya hai taaki purane issues ka asar future par na pade. Agle quarters mein nazar rakhein ki kya ye badhta hua revenue ab bottom-line (profit) mein badal paata hai ya nahi.